Active Stock Alerts: Akorn, Maxwell Technologies, Netflix, Citi, Gilead Sciences May 17th

Netflix, Inc. (NASDAQ:NFLX): Needham believes that increases in Netflix’s domestic streaming margins will be largely offset by a decline in higher margin DVD subscription revenues. The firm doesn’t rule out the possibility that the company could increase the margins of its international business over the longer term, but maintains an Underperform rating for now.

Akorn Inc. (NASDAQ:AKRX): Piper Jaffray raised its price target for Akorn after meeting with management citing the company’s compelling growth prospects, and keeps an Overweight rating on the stock.

Maxwell Technologies Inc. (NASDAQ:MXWL): ThinkEquity expects Maxwell’s profitability to increase in 2012 and 2013, and the firm maintains a $19 target and Buy rating on the stock.

Citi Trends (NASDAQ:CTRN): Wells Fargo increased its valuation range on Citi Trends after the company reported higher than expected Q1 EPS. The firm believes that the company’s EPS could rise further over the next few quarters and it reiterates an Outperform rating on the stock.

Gilead Sciences Inc. (NASDAQ:GILD): After speaking with U.S. payers, Wells Fargo expects Gilead to remain the dominant marketer of HIV treatments for the foreseeable future. The firm expects most insurers to cover Gilead’s Quad immediately after it’s launched, and Wells maintains an Outperform rating on the stock.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.